Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice

Synapse
Valeria T PedrónGraciela N Balerio

Abstract

In previous studies we have shown that baclofen, a selective GABAB receptor agonist, prevents the somatic expression and reestablishes the dopamine and μ-opioid receptors levels, modified during naloxone-precipitated morphine withdrawal syndrome in male and female mice. There are no previous reports regarding sex differences in the elevated plus maze (EPM) and the expression of BDNF in morphine-withdrawn mice. The present study analyses the behavioral and biochemical variations during morphine withdrawal in mice of both sexes, and whether these variations are prevented with baclofen. Swiss-Webster albino prepubertal mice received morphine (2 mg/kg, i.p.) twice daily, for 9 consecutive days. On the 10th day, one group of morphine-treated mice received naloxone (opioid receptor antagonist; 6 mg/kg, i.p.) 1 h after the last dose of morphine to precipitate withdrawal. A second group received baclofen (2 mg/kg, i.p.) before naloxone administration. The EPM behavior was measured during 15 min after naloxone injection. The expression of BDNF-positive cells was determined by immunohistochemistry. Withdrawn male mice showed a higher percentage of time spent and number of entries to the open arms compared to withdrawn female mice. Baclof...Continue Reading

References

Aug 1, 1992·Pharmacology, Biochemistry, and Behavior·J CandidoB C Yoburn
Oct 1, 1989·Trends in Pharmacological Sciences·N Bowery
Jan 1, 1995·Annual Review of Neuroscience·D W Self, E J Nestler
Nov 11, 1999·European Journal of Pharmacology·M R Zarrindast, E Mousa-Ahmadi
Dec 20, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·K N GracyG F Koob
Oct 3, 2001·The American Journal on Addictions·E J Nestler
Oct 5, 2001·Nature Reviews. Neuroscience·S E Hyman, R C Malenka
Dec 10, 2002·Neurochemistry International·Silvina L DiazGraciela N Balerio
Mar 6, 2004·Neuromolecular Medicine·Carlos A Bolaños, Eric J Nestler
May 3, 2005·Behavioural Pharmacology·I BrosetaJ Minarro
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·James R Shoblock, Nigel T Maidment
Dec 6, 2005·Pharmacology, Biochemistry, and Behavior·Silvina L DiazGraciela N Balerio
May 23, 2006·Gene Expression Patterns : GEP·M J WebsterC Shannon Weickert
Oct 31, 2006·Frontiers in Neuroendocrinology·Farida Sohrabji, Danielle K Lewis
Jun 16, 2007·Biopharmaceutics & Drug Disposition·Silvina L DiazGraciela N Balerio
Mar 1, 2008·Pharmacology, Biochemistry, and Behavior·Zhongqi Zhang, Gery Schulteis
Apr 9, 2008·Pharmacology & Therapeutics·Margaret I Davis
Jul 19, 2008·Behavioural Brain Research·Esmail RiahiAhmad Reza Dehpour
Nov 21, 2008·Behavioural Pharmacology·Stephen R HodgsonShoshana Eitan
Feb 12, 2009·Stress : the International Journal on the Biology of Stress·Mohammed RabbaniAzadeh Mesripour
May 30, 2009·Science·Hector Vargas-PerezDerek van der Kooy
Sep 8, 2009·Brain Research·Jacqueline F McGintyWilliam J Berglind
Nov 17, 2009·Neuroscience and Biobehavioral Reviews·Udi E GhitzaLin Lu
Sep 3, 2011·Brain Research·Lihong WanZhengrong Wang
Mar 21, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Andrés P Varani, Graciela N Balerio

❮ Previous
Next ❯

Citations

Jun 27, 2019·The Journal of Pharmacology and Experimental Therapeutics·Jenny L WilkersonLance R McMahon
Jun 19, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A P VaraniG N Balerio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.